Last updated on November 2018

A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)


Brief description of study

M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Clinical Study Identifier: NCT02975336

Contact Investigators or Research Sites near you

Start Over

Gonzalo Crespi

Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Hugo Laborde

Hospital Britanico de Buenos Aires
Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Eduardo Kerzberg

Hospital General de Agudos Dr. J. M. Ramos Mejia
Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Pablo Alejandro Mannucci

APRILLUS
Ciudad Autonoma Buenos aires, Argentina
  Connect »